Drug Approval | March 19, 2024
Carbogen Amcis (Shanghai) completed ANVISA Audit
A five-day inspection was concluded successfully with no critical and no major observations raised
A five-day inspection was concluded successfully with no critical and no major observations raised
The inspection was concluded with few procedural observations
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
Dishman Carbogen Amcis has reported total income of Rs. 729.91 crores during the period ended June 30, 2023
Carbogen Amcis Manchester won the industry award in recognition of its efficiency improvement program implemented in response to increased demand for its products
The company has announced net revenue of Rs. 639.8 crore for Q3 FY23 as compared to Rs. 562.08 crore in the corresponding period of the previous year
This inspection continues a series of successful inspections by Swissmedic in Vionnaz with the first inspection in 2015 followed by 2016, 2017 and 2020.
Dishman Carbogen Amcis has reported consolidated financial results for the period ended December 31, 2021
The co-investment of CHF 4 million will result in capacity expansion and support the market introduction of the customer's lead compound
Researchers observed that a form of vitamin D, known as 25-hydroxyvitamin D3 (Calcifediol), was absorbed faster and better than the same dose of vitamin D.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)